Stay updated on Pembrolizumab as AML Post-Remission Treatment Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab as AML Post-Remission Treatment Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab as AML Post-Remission Treatment Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now indicates no participants are being sought and adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the Intervention/Treatment label formatting and changes the release note from Revision: v3.5.5 to Revision: v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-13T00:39:38.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision updated to v3.5.5, indicating a software version update for the page. This change does not modify study details or other user-facing content.
    Difference
    0.1%
    Check dated 2026-06-05T16:26:00.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    The page has updated its revision number from v3.5.3 to v3.5.4, indicating a minor site update. The update does not alter the displayed study details or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-05-15T05:22:27.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.5.2 to v3.5.3, representing a new build of the site. This update does not alter the study details or any information presented to users.
    Difference
    0.1%
    Check dated 2026-04-30T18:35:02.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Revision: v3.5.2 is now shown, replacing Revision: v3.5.0. This indicates a site update rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-04-16T10:45:12.000Z thumbnail image
  7. Check
    97 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T15:44:50.000Z thumbnail image

Stay in the know with updates to Pembrolizumab as AML Post-Remission Treatment Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab as AML Post-Remission Treatment Clinical Trial page.